Physician profile
Daniel P Raymond
NPI 1861420796
$15,368.34
in general payments reported to CMS, 2019-2025
13 companies · $5,559 in 2025
The $5,559 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2021: $4,525 · 2022: $2,115 · 2023: $2,402 · 2024: $398 · 2025: $5,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,750 · Consulting Fee: $1,880 · Food and Beverage: $1,679 · Travel and Lodging: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,750.00 |
| Consulting Fee | $1,879.50 |
| Food and Beverage | $1,679.20 |
| Travel and Lodging | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $11,104.03 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $3,075.18 | 2021-2023 | Imfinzi |
| Edwards Lifesciences Corporation | $221.63 | 2025 | |
| Dilon Technologies, INC. | $183.17 | 2024-2025 | Hemoblast Bellows |
| Ethicon US, LLC | $181.12 | 2019-2024 | Ethicon |
| Davol INC. | $160.73 | 2022 | |
| Atricure, INC. | $129.33 | 2022-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Zimmer Biomet Holdings, INC. | $123.73 | 2024 | Sternalock Blu System |
| Medtronic, INC. | $68.08 | 2024-2025 | Avalus, Endo Gia Ultra, Onyx Frontier |
| Baxter Healthcare | $41.68 | 2025 | Tisseel |
| Covidien Lp | $36.21 | 2019 | |
| Abiomed | $28.08 | 2025 | |
| Intuitive Surgical, INC. | $15.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Raymond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.